Orthopedics and Spine
SeaSpine Acquiring 7D Surgical for $110M
SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today that it has entered into an agreement to acquire all of the issued and outstanding shares of 7D Surgical, Inc., a privately-held, Toronto-based company, in a cash and stock deal valued at $110 million, subject to customary…
Read MoreCatalyst OrthoScience Receives FDA 510(k) Clearance of Its Reverse Shoulder System
Catalyst OrthoScience Inc. (Catalyst), a medical device company focused on the upper extremity orthopedics market, has received clearance from the U.S. Food & Drug Administration (FDA) to market its reverse shoulder system. Catalyst expects to begin a limited user release in the United States in the second quarter of 2021 followed by a commercial launch later…
Read MoreNuVasive Acquires Simplify Medical
NuVasive, Inc., the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced that it has acquired Simplify Medical, a privately held company and developer of the Simplify® Cervical Artificial Disc (Simplify Disc) for cervical total disc replacement (cTDR). The acquisition of Simplify Medical adds the most clinically…
Read MoreAcuitive Technologies Wins FDAClearance for Tendon Interference Screw System
Acuitive Technologies announced last week that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the CITREFIX™ Knotless Suture Anchor System with CITREGEN™ material technology, a new generation bioresorbable synthetic polymer. The CITREFIX system is intended to assist the attachment of tissue to bone during orthopedic surgeries such as…
Read MoreZimmer Biomet Spinning Off Spine & Dental Business
Zimmer Biomet (Formerly Known As Biomet Inc.) Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, announced its intention to spin off the Company’s Spine and Dental businesses to form a new and independent, publicly traded company (“NewCo”). The planned transaction will enhance the focus of both Zimmer Biomet and NewCo to…
Read MoreLocate Bio’s CognitOss Lands FDA Breakthrough Device Designation
Locate Bio, an orthobiologics focused regenerative medicine company, is pleased to announce that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device designation to CognitOss, currently in development for the treatment of chronic osteomyelitis. The FDA Breakthrough Device Program is intended to help patients receive more timely access to certain technologies that have…
Read MoreStryker Acquires OrthoSensor, Adds Knee Surgery Sensor Technology to Portfolio
Stryker announced today the acquisition of OrthoSensor, Inc., a privately held company founded in 2007 and headquartered in Dania Beach, FL. OrthoSensor, Inc., is a leader in the digital evolution of musculoskeletal care and sensor technology for total joint replacement. “Smart devices and implants will play a big role in orthopaedics and we are excited…
Read MoreMiach Orthopaedics’ ACL Tear Device Granted FDA De Novo Approval
Miach Orthopaedics, Inc., a privately held company dedicated to developing bio-engineered surgical implants for connective tissue repair, today announced that the U.S. Food & Drug Administration has granted the company’s De Novo Request for the Bridge-Enhanced® ACL Repair (BEAR®) Implant, resulting in marketing approval for the treatment of anterior cruciate ligament (ACL) tears, one of the…
Read MoreFDA Grants Breakthrough Device Designation for Spiderwort Spinal Cord Technology
Spiderwort Inc., a Canadian medical device company developing innovative biomaterials for regenerative medicine, is pleased to announce that the U.S. Food and Drug Administration (FDA) has designated CelluBridgeTM, Spiderwort’s Spinal Cord Scaffold Implant, as a “Breakthrough Device”. The FDA Breakthrough Devices program creates a path for innovators to get their medical devices to market faster. The program…
Read MoreCerapedics Announces Commercial Launch of i-FACTOR+ Matrix in Canada
Cerapedics, a private ortho-biologics company, today announced the full commercial availability of i-FACTOR+ MATRIX for surgical implantation in Canada. “We are excited to announce that i-FACTOR+ Matrix is now fully available in Canada through our distributor Surgi-One and can be used in both spine and general orthopedic applications,” said Glen Kashuba, Chief Executive Officer of Cerapedics. “Canada will be the…
Read More